drugset / Trial / NCT04312698

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

NCT04312698

Phase 3 Completed 100 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Timeline

Start
2019-08-29
Primary completion
2021-06-18
Completion
2021-06-18

Drugs

EvaluationDrugModalityDoseRoute
Subject D013 Unknown
Subject D326 Unknown
Subject D337 Unknown

Indications